Drug Trial Radar · NCT02275117
A Multicenter Assessment of ALD403 in Chronic Migraine
Last checked: Nov 20, 2026Latest source record: Apr 8, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
665
Actual
Start
Oct 2014
Primary completion
Mar 2016
Study completion Nov 2016
Sponsor
- Lead sponsor
- Alder Biopharmaceuticals, Inc.Industry
- Sponsor type
- Industry
- First posted
- Oct 27, 2014
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Prevention
- Who can join
- All sexes, from 18 years, up to 55 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to assess ALD403 in the prevention of migraine headache in chronic migraineurs.
Conditions
- Migraine Disorders
Interventions
ALD403Biological
PlaceboBiological
Primary outcomes
What the sponsor says the trial is designed to measure.
- 75% Migraine Responder RateTime frame: 12 Weeks
Locations
92 sites in 4 countries. Site status is shown where the registry gives one.
Research Site
Huntsville, Alabama
Research Site
Mobile, Alabama
Research Site
Phoenix, Arizona
Research Site
Scottsdale, Arizona
Research Site
Hot Springs, Arkansas
Research Site
Little Rock, Arkansas
Research Site
Anaheim, California
Research Site
Encino, California
Reserach Site
Long Beach, California
Research Site
Los Angeles, California
Research Site
Oakland, California
Research Site
San Diego, California
Research Site
San Francisco, California
Research Site
Santa Monica, California
Research Site
Stanford, California
Research Site
Ventura, California
Research Site
Colorado Springs, Colorado
Research Site
Denver, Colorado
Research Site
Stamford, Connecticut
Research Site
Waterbury, Connecticut
Research Site
Gainesville, Florida
Research Site
Hallandale, Florida
Research Site
Jacksonville, Florida
Research Site
Miami, Florida
Research Site
Miami, Florida
Research Site
North Miami, Florida
Research Site
Orlando, Florida
Research Site
Orlando, Florida
Research Site
Tampa, Florida
Research Site
Atlanta, Georgia
Research Site
Atlanta, Georgia
Research Site
Chicago, Illinois
Research Site
Chicago, Illinois
Research Site
Evansville, Illinois
Research Site
Normal, Illinois
Research Site
Prairie Village, Kansas
Research Site
Wichita, Kansas
Research Site
Louisville, Kentucky
Research Site
New Orleans, Louisiana
Research Site
Shreveport, Louisiana
Showing 40 of 92 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.